drugset / Trial / NCT02183480
Dose Proportionality of Different Dose Strengths of Linagliptin Tablets After Oral Administration to Healthy Male and Female Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
Study to assess the pharmacokinetics and dose proportionality of 1 mg, 2.5 mg and 5 mg tablets of linagliptin
Timeline
- Start
- 2009-07
- Primary completion
- 2009-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Linagliptin | Small molecule | 1 mg | Oral |
| Subject | Linagliptin | Small molecule | 2.5 mg | Oral |
| Subject | Linagliptin | Small molecule | 5 mg | Oral |
Indications
No indication recorded.